LOINC
Version 2.73

LP185667-5PrulifloxacinActive

Description

LP185667-5   Prulifloxacin
Prulifloxacin is an oral, broad spectrum fluoroquinolone antimicrobial drug. It is metabolized to ulifloxacin, its active form, by first pass metabolism in the liver. It is effective against both gram positive and gram negative bacteria, and indications for use include urinary tract infection and exacerbation of chronic bronchitis. [PMID:18044063] Source: Regenstrief LOINC, PMID: 18044063

Basic Part Properties

Name
Prulifloxacin
Type
Component
Created On
2014-07-27
Construct for LOINC Short Name
Prulifloxacin

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP185667-5

Language Variants Get Info

zh-CNChinese (China)
普卢沙星
Synonyms: 普卢利沙星;普利沙星;喹诺酮类抗菌药;鲁丽沙星;Prulifloxacin;NM-441;6-Fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3thiazer0[3,2-a]quinoline-3-carboxylic acid;CAS 123447-62-1
nl-NLDutch (Netherlands)
prulifloxacine
fr-CAFrench (Canada)
Prulifloxacine
it-ITItalian (Italy)
Prulifloxacina
es-ESSpanish (Spain)
Prulifloxacina
tr-TRTurkish (Turkey)
Prulifloksasin